SERUM MATRIX METALLOPROTEINASE-9 LEVELS AND CARDIOVASCULAR RISK RATES IN SUBJECTS WITH METABOLIC SYNDROME

Tarih
2015
Yazar
Utku, Irem
Harmankaya, Ozlem
Demir, Esra
Kocoglu, Hakan
Ucak, Sema
Serin, Sibel Ocak
OKUTURLAR, Yıldız
GEDİKBAŞI, Asuman
Üst veri
Tüm öğe kaydını göster
Özet
Introduction: The present study aimed to evaluate and to compare Framingham Risk Score (FRS), a prediction tool for 10 year risk of coronary heart disease, and Matrix Metalloproteinase-9 (MMP-9) levels (an atherosclerotic proinflammatory marker) in patients with metabolic syndrome (MetS).
Bağlantı
http://hdl.handle.net/20.500.12627/138251
Koleksiyonlar